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as mechanical noise to the soles of the
feet, or when applied as electrical noise at
the knee and to the back muscles.
SR using imperceptible stochastic
electrical stimulation of the vestibular
system (stochastic vestibular stimulation,
SVS) applied to normal subjects has
shown to improve the degree of associa-
tion between the weak input periodic
signals introduced via venous blood
pressure receptors and the heart-rate re-
sponses. Also, application of SVS over 24
hours improves the long-term heart-rate
dynamics and motor responsiveness as
indicated by daytime trunk activity meas-
urements in patients with multi-system
atrophy, Parkinson’s disease, or both, in-
cluding patients who were un responsive
to standard therapy for Parkinson’s dis-
ease. Recent studies conducted at the
NASA JSC Neurosciences Laboratories
showed that imperceptible SVS, when
applied to normal, young, healthy sub-
jects, leads to significantly improved bal-
ance performance during postural dis-
turbances on unstable compliant
surfaces. These studies have shown the
benefit of SR noise characteristic opti-
mization with imperceptible SVS in the
frequency range of 0–30 Hz, and ampli-
tudes of stimulation have ranged from
100 to 400 microamperes.
This work was done by Jacob Bloomberg
and Millard Reschke of Johnson Space Cen-
ter; Ajitkumar Mulavara and Scott Wood of
USRA; Jorge Serrador of Dept. of Veterans Af-
fairs NJ Healthcare System; Matthew Fiedler,
Igor Kofman, and Brian T. Peters of Wyle;
and Helen Cohen of Baylor College. For fur-
ther information, contact the JSC Innovation
Partnerships Office at (281) 483-3809.
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Several technological enhancements
have been made to METI’s commercial
Emergency Care Simulator (ECS) with
regard to how microgravity affects
human physiology. The ECS uses both a
software-only lung simulation, and an in-
tegrated mannequin lung that uses a
physical lung bag for creating chest ex-
cursions, and a digital simulation of lung
mechanics and gas exchange. METI’s
patient simulators incorporate models
of human physiology that simulate lung
and chest wall mechanics, as well as pul-
monary gas exchange.
Microgravity affects how O2 and CO2
are exchanged in the lungs. Procedures
were also developed to take into affect
the Glasgow Coma Scale for determin-
ing levels of consciousness by varying the
ECS eye-blinking function to partially in-
dicate the level of consciousness of the
patient. In addition, the ECS was modi-
fied to provide various levels of pulses
from weak and thready to hyper-dy-
namic to assist in assessing patient con-
ditions from the femoral, carotid,
brachial, and pedal pulse locations. 
This work was done by Nigel Parker and
Veronica O’Quinn of Medical Education
Tech, Inc. for Johnson Space Center. Further
information is contained in a TSP (see page
1). MSC-23922-1
Developing Physiologic Models for Emergency Medical
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The most common approach for as-
sessing the abundance of viable bacter-
ial endospores is the culture-based plat-
ing method. However, culture-based
approaches are heavily biased and of-
tentimes incompatible with upstream
sample processing strategies, which
make viable cells/spores uncultivable.
This shortcoming highlights the need
for rapid molecular diagnostic tools to
assess more accurately the abundance
of viable spacecraft-associated micro-
biota, perhaps most importantly bacter-
ial endospores.
Propidium monoazide (PMA) has re-
ceived a great deal of attention due to
its ability to differentiate live, viable
bacterial cells from dead ones. PMA
gains access to the DNA of dead cells
through compromised membranes.
Once inside the cell, it intercalates and
eventually covalently bonds with the
double-helix structures upon photoac-
tivation with visible light. The cova-
lently bound DNA is significantly al-
tered, and unavailable to downstream
molecular-based manipulations and
analyses. Microbiological samples can
be treated with appropriate concentra-
tions of PMA and exposed to visible
light prior to undergoing total genomic
DNA extraction, resulting in an extract
comprised solely of DNA arising from
viable cells. This ability to extract DNA
selectively from living cells is extremely
powerful, and bears great relevance to
many microbiological arenas.
While this PMA-based selective chem-
istry has been applied to several poly-
merase chain reaction (PCR)-based
molecular protocols, it has never been
coupled with fluorescence in situ hy-
bridization (FISH)-based microscopic
methods. FISH microscopy is a power-
ful technique for visualizing and enu-
merating microorganisms present in a
given sample, which relies on the ability
of fluorescently labeled oligonu-
cleotide probes to gain access to, and
hybridize with, specific nucleic acid se-
quences within cells. Dogmatic princi-
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ples suggest that by first treating a sam-
ple with PMA and covalently modifying
the DNA originating from dead cells,
downstream FISH-based mi croscopy
should then enable the direct, specific
visualization and enumeration of only
living, viable microorganisms. An effec-
tive and efficient coupling of PMA-
based chemistry with downstream
FISH-microscopic methods would sig-
nificantly empower the current ability
to discern viable from dead microbes
by direct visualization.
The basic principle of this method is
that PMA penetrates only the dead cells
and/or spores, due to their compro-
mised membrane structures. Once in-
side the cell, PMA strongly intercalates
with DNA. PMA has a photoactive azide
group that allows covalent cross-linkage
to DNA upon exposure to bright white
light. This photoactivation results in the
formation of PMA-DNA complex that
renders DNA inaccessible for hybridiza-
tion reaction during FISH assay. To
avoid the difficulties and problems asso-
ciated with current methods for deter-
mining the actual numbers of living ver-
sus dead cellular entities examined, and
biases associated therewith, a novel mo-
lecular-biological protocol was devel-
oped for selective detection and enu-
meration of viable microbial cells. After
having been subjected to the procedures
described herein, the viability (live vs.
dead) of bacterial cells and spores could
be discerned. Following treatment with
PMA, living, viable cells and spores were
shown to be receptive to fluorescently la-
beled oligonucleotide probes, as hy-
bridization and FISH-based mi cros copy
was successful. Dead cells and spores,
however, were not detected, as the pre-
treatment with PMA rendered their
DNA unavailable to hybridization with
the FISH-probes.
The true novelty of the technology is
the coupling of a downstream, highly
specific means of visualizing microbial
cells and spores with a chemical pre-
treatment that precludes the portion of
the microbial consortium that is not 
living (non-viable) from being detected.
This results in the ability to selectively 
visualize and enumerate only the living
cells and spores present in a given sam-
ple, in a molecular biological fashion,
without the need for heavily biased culti-
vation-based methodologies. This novel
study demonstrates that PMA penetrates
only the heat-killed spores, which pre-
cludes downstream hybridization reac-
tions in the FISH assay. This novel PMA-
FISH method is an attractive tool to
detect viable endospores in space craft-
associated environments, which is of
crucial importance and benefit to plane-
tary protection practices aimed at reduc-
ing the abundance of spacecraft-borne
microbial contaminants.
This work was done by Myron T. La Duc
and Kasthuri Venkateswaran of Caltech, and
Bidyut Mohapatra of the University of South
Alabama for NASA’s Jet Propulsion Labora-
tory. For more information, contact
iaoffice@jpl.nasa.gov.
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There are several medical conditions
that require intravenous (IV) fluids.
Limitations of mass, volume, storage
space, shelf-life, transportation, and
local resources can restrict the availabil-
ity of such important fluids. These limi-
tations are expected in long-duration
space exploration missions and in re-
mote or austere environments on Earth.
Current IV fluid production requires
large factory-based processes. Easy,
portable, on-site production of IV fluids
can eliminate these limitations. Based
on experience gained in developing a
device for spaceflight, a ground-use de-
vice was developed.
This design uses regular drinking
water that is pumped through two filters
to produce, in minutes, sterile, ultra-
pure water that meets the stringent
quality standards of the United States
Pharmacopeia for Water for Injection
(Total Bacteria, Conductivity, Endo -
toxins, Total Organic Carbon). The de-
vice weighs 2.2 lb (1 kg) and is 10 in.
long, 5 in. wide, and 3 in. high (≈25, 13,
and 7.5 cm, respectively) in its storage
configuration. This handheld device
produces one liter of medical-grade
water in 21 minutes. Total production
capacity for this innovation is expected
to be in the hundreds of liters. 
The device contains one battery pow-
ered electric mini-pump. Alternatively,
a manually powered pump can be at-
tached and used. Drinking water enters
the device from a source water bag,
flows through two filters, and final ster-
ile production water exits into a sealed,
medical-grade collection bag. The col-
lection bag contains pre-placed crys-
talline salts to mix with product water
to form isotonic intravenous medical
solutions. Alternatively, a hypertonic
salt solution can be injected into a filled
bag. The filled collection bag is de-
tached from the device and is ready for
use or storage. This device currently
contains one collection bag, but a man-
ifold of several pre-attached bags or re-
placement of single collection bags
under sterile needle technique is possi-
ble for the production of multiple
liters. The entire system will be flushed,
sealed, and radiation-sterilized.
Operation of the device is easy and re-
quires minimal training. Drinking water
is placed into the collection bag. Inline
stopcock flow valves at the source and
collection bags are opened, and the
mini-pump is turned on by a switch to
begin fluid flow. When the collection
bag is completely filled with the med-
ical-grade water, the pump can be
turned off. The pump is designed so it
cannot pump air, and overfilling of the
collection bag with fluid is avoided by
placing an equal amount of water in the
source bag. Backflow is avoided by in-
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